Use of Bone Morphogenetic Protein Among Patients Undergoing Fusion for Degenerative Diagnoses in the United States, 2002–2012

BACKGROUND CONTEXT: Use of Bone Morphogenetic Protein (BMP) as an adjunct to spinal fusion surgery proliferated following Food and Drug Administration (FDA) approval in 2002. Major safety concerns emerged in 2008. PURPOSE: To examine whether published concerns about the safety of BMP altered clinica...

全面介紹

Na minha lista:
書目詳細資料
發表在:Spine J
Main Authors: Martin, Brook I., Lurie, Jon D., Deyo, Richard A., Tosteson, Anna N.A., Farrokhi, Farrokh Reza, Mirza, Sohail K.
格式: Artigo
語言:Inglês
出版: 2014
主題:
Article
在線閱讀:https://ncbi.nlm.nih.gov/pmc/articles/PMC4375057/
https://ncbi.nlm.nih.gov/pubmed/25523380
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.spinee.2014.12.010
標簽: 添加標簽
沒有標簽, 成為第一個標記此記錄!

相似書籍